| RS1555527341 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS1555527450 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527464 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527495 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527497 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555527511 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555527513 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527532 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527732 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527741 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527743 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS1555527745 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527806 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527877 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Malignant lymphoma |
| RS1555527907 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555527929 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS1555528040 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555528181 |
ACADVL
|
Health Risk |
Likely pathogenic |
— |
| RS1555528188 |
ACADVL
|
Health Risk |
Likely pathogenic |
— |
| RS1555528265 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528304 |
ACADVL
|
Health Risk |
Pathogenic/Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528354 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, ANKRD11-related disorder |
| RS1555528356 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS1555528357 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555528367 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528386 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528400 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1555528508 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528558 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555528635 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528717 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555528719 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555528737 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528745 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528804 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555528937 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555529004 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555529044 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555529048 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555529052 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555529181 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1555529204 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1555529297 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555529364 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555529551 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1555529572 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555529645 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, KBG syndrome |
| RS1555529726 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, KBG syndrome |
| RS1555529734 |
ANKRD11
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, KBG syndrome |
| RS1555529864 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555529979 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS1555530022 |
MAF
|
Health Risk |
Pathogenic |
Cataract 21 multiple types, Ayme-Gripp syndrome |
| RS1555530054 |
MAF
|
Health Risk |
Pathogenic |
— |
| RS1555530080 |
MAF
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555530173 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555530551 |
TTC19
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS1555531276 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS1555531314 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555531333 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS1555531360 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS1555531363 |
KIAA0753
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 21 without polydactyly, Joubert syndrome |
| RS1555531387 |
FOXC2
|
Health Risk |
Likely pathogenic |
— |
| RS1555531390 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1555532483 |
C1QBP
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 33, Combined oxidative phosphorylation deficiency 33 |
| RS1555532484 |
C1QBP
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 33, Combined oxidative phosphorylation deficiency 33 |
| RS1555532943 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555532944 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555532946 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555532979 |
WWOX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 28 |
| RS1555533265 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555533268 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533284 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533285 |
NF1
|
Health Risk |
Pathogenic |
Neurofibroma, Cafe au lait spots |
| RS1555533288 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533290 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533292 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533297 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533300 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555533305 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533307 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533313 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555533323 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533326 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533336 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533338 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533342 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533347 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533351 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533354 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533359 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533363 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533366 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533368 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533382 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533393 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533395 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533409 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555533416 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533541 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS1555533543 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |